1. Evaluation of 9-cis retinoic acid for a new remedy of human retinoblastoma
- Author
-
Hidetoshi Tsukamoto, Sadahiko Ishibashi, Hiromu K. Mishima, Tomonori Kurokawa, and Kohji Hirata
- Subjects
Programmed cell death ,Time Factors ,Cell Survival ,Clinical Biochemistry ,Retinoic acid ,Antineoplastic Agents ,Tretinoin ,Biochemistry ,Inhibitory Concentration 50 ,chemistry.chemical_compound ,Alitretinoin ,Tumor Cells, Cultured ,Genetics ,medicine ,Humans ,Viability assay ,Molecular Biology ,IC50 ,Dose-Response Relationship, Drug ,Cell growth ,Retinoblastoma ,Trypan Blue ,Cell Biology ,medicine.disease ,Molecular biology ,eye diseases ,Dose–response relationship ,chemistry ,Immunology ,Cell Division ,medicine.drug - Abstract
We investigated the effect of two isomers of retinoic acid (RA), all-trans RA and 9-cis RA, on the proliferation of Y79 human retinoblastoma cells. The two isomers inhibited the cell proliferation in a concentration-dependent manner. The IC50 for this inhibition by all-trans RA and 9-cis RA was 1.50 and 0.15 microM, respectively. The inhibitory effect of 9-cis RA on Y79 cell growth was observed within 24 hr, thereafter the cell number was gradually decreased. In contrast, no inhibition by all-trans RA of Y79 cell growth was observed within 24 hr, thereafter the cell number was slightly increased. In these cases, the cell viability at 4 days after the addition of 9-cis RA and all-trans RA was more than 90% and 95%, respectively. These results indicate that the two RA inhibit the proliferation of Y79 human retinoblastoma cells without inducing the cell death and that the effect of 9-cis RA on the inhibition of Y79 cell growth is much greater than that of all-trans RA.
- Published
- 1998
- Full Text
- View/download PDF